Fresenius Medical Care AG (ETR:FME – Get Free Report)’s share price reached a new 52-week high on Tuesday . The stock traded as high as €42.81 ($45.06) and last traded at €41.97 ($44.18), with a volume of 341750 shares. The stock had previously closed at €43.00 ($45.26).
Fresenius Medical Care Stock Performance
The stock has a market cap of $12.31 billion, a P/E ratio of 23.34, a PEG ratio of 0.42 and a beta of 0.86. The stock has a fifty day simple moving average of €38.28 and a 200-day simple moving average of €37.32. The company has a debt-to-equity ratio of 77.56, a quick ratio of 0.80 and a current ratio of 1.46.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Articles
- Five stocks we like better than Fresenius Medical Care
- Technology Stocks Explained: Here’s What to Know About Tech
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- What is Short Interest? How to Use It
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
